About Thomas Brenninkmeijer
Thomas Brenninkmeijer is a director at Goldenrod Therapeutics.
Experience
This experience comes from SEC filings. The years are when the filings name Thomas Brenninkmeijer in the role, so the role may have started earlier or lasted longer.
Goldenrod Therapeutics, Inc.
Director
2026 · Houston, TX
Develops medicines for people with neurological diseases, initially targeting Friedreich’s ataxia.
Key Colleagues at Startups
The people Thomas Brenninkmeijer works with at each company, as listed on that company's latest Form D.
Goldenrod Therapeutics, Inc. · Form D, Jun 3, 2026
Dev Chatterjee
Chief Executive Officer
LI
Leo Linbeck IV
Executive officer
Mark Worscheh
Chief Financial Officer and director
Atul Varadhachary
President and director
LI
Leo Linbeck III
Director